CANCER SUPPORT
1300 881 698
CANCER SUPPORT | 1300 881 698
April is Oesophageal Cancer Awareness Month.
Chris Capstick
Oesophageal Cancer is considered a rare cancer with low survival rates and little recognition. Raising funds and awareness for Oesophageal cancer helps
PBAC recommends subsidised therapies for biliary and oesophageal cancers
Nikki Rynia
The Pharmaceutical Benefits Advisory Committee (PBAC) last week announced two positive recommendations for therapies that will benefit biliary and oesophageal cancer patients. The therapies brought
New PBAC application supports immunotherapy treatment for oesophageal and gastro-oesophageal junction cancers
Pancare is supporting Bristol Meyers Squibb in their application to the Pharmaceutical Benefits Advisory Committee (PBAC) for the funding of Nivolumab, an immunotherapy for the treatment of
Advocating for upper GI cancers: oesophageal and gastric cancer update
An important part of Pancare supporting patients with upper gastrointestinal (GI) cancers is advocating for better treatment and unmet needs.